WHO ICTRP trial

Functional magnetic resonance imaging of Parkinson*s disease patients to…

NL-OMON44476 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting

Key facts

Trial ID NL-OMON44476
Public title Functional magnetic resonance imaging of Parkinson*s disease patients to investigate the effects of dopamine on visual attention.
Scientific title Functional magnetic resonance imaging of Parkinson*s disease patients to investigate the effects of dopamine on visual attention. - PD and the role of dopamine in visual attention
Primary sponsor Vrije Universiteit
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Not Recruiting
Study type Interventional
Countries The Netherlands
Conditions Parkinson's disease;10028037;Parkinson's disease
Interventions Cognitive performance measurements of PD patients when on L-DOPA medication and during a practically-defined off-medication state (i.e. following overnight withdrawal of dopamine medication). ;fMRI;Parkinson's;Reward;Visual attention
Registration date Mar 30, 2016
Target size 48
Secondary IDs NL47760.029.14
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations